Katie Young told Newsweek: "My entire life, I was the only woman I had ever known who had not started her period." ...

The birth control drug name-dropped in Project 2025 is suddenly getting new attention, thanks to research suggesting it could ...

Former two-weight UFC champion, Daniel Cormier has rekindled his rivalry with fellow ex-two-weight titleholder, Jon Jones - excluding him from the debate as ...

We read with interest the article by Marie Lund and colleagues published in The Lancet Oncology investigating the association ...

During a Case-Based Roundtable event, Laura Huppert, MD, discussed data and considerations around using T-DXd in breast ...

Once Kenya's shining athletic talent, Alice Aprot Nawowuna has now faced a life changing moment, leaving many to wonder where her once-brilliant future has gone.

If the trial is successful, the firm's complete estrogen receptor antagonist would complement its other biomarker-driven breast cancer assets.

The Phase III trial saw a clinically meaningful benefit in overall survival with a combination of Itovebi alongside Ibrance ...

This study presents fundamental insights into overcoming resistance in hormone receptor-positive breast cancer by demonstrating that sustained CDK4/6 inhibitor treatment, either alone or in ...

Discover the role of phytoestrogens, including soy, in menopause management and breast cancer prevention. Learn how these ...

Operator Good day, everyone and welcome to Pfizer's fourth-quarter 2024 earnings conference call. Today's call is being ...